All Stories

  1. A Randomized Trial of Brief Versus Extended Seizure Prophylaxis After Aneurysmal Subarachnoid Hemorrhage
  2. SANGUINATE™ (PEGylated Carboxyhemoglobin Bovine) Improves Cerebral Blood Flow to Vulnerable Brain Regions at Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
  3. Are We Fortune Tellers or Healers?*
  4. RBC Transfusion Improves Cerebral Oxygen Delivery in Subarachnoid Hemorrhage
  5. Neurologic manifestations of major electrolyte abnormalities
  6. Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachn...
  7. Decompressive Hemicraniectomy in the Age of Personalized Medicine
  8. Early Withdrawal Decision-Making in Patients with Coma After Cardiac Arrest: A Qualitative Study of Intensive Care Clinicians
  9. Acute Effect of Intravenous Sildenafil on Cerebral Blood Flow in Patients with Vasospasm After Subarachnoid Hemorrhage
  10. The Evolution of the Clinical Use of Osmotic Therapy in the Treatment of Cerebral Edema
  11. Effect of High-Dose Simvastatin on Cerebral Blood Flow and Static Autoregulation in Subarachnoid Hemorrhage
  12. A Consensus-Based Interpretation of the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure Trial
  13. The Role of Osmotic Therapy in Hemispheric Stroke
  14. Cognition and Quality-of-Life Outcomes in the Targeted Temperature Management Trial for Cardiac Arrest
  15. Regional Brain Monitoring in the Neurocritical Care Unit
  16. Defining the Ischemic Penumbra Using Magnetic Resonance Oxygen Metabolic Index
  17. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage
  18. The International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: A List of Recommendations and Additional Conclusions
  19. The International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: Evidentiary Tables
  20. Treatment of Subarachnoid Hemorrhage
  21. Understanding the disease: aneurysmal subarachnoid hemorrhage
  22. Consensus Summary Statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care
  23. Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care
  24. Relationship Between Angiographic Vasospasm, Cerebral Blood Flow, and Cerebral Infarction After Subarachnoid Hemorrhage
  25. Racial differences in withdrawal of mechanical ventilation do not alter mortality in neurologically injured patients
  26. Pattern Not Volume of Bleeding Predicts Angiographic Vasospasm in Nonaneurysmal Subarachnoid Hemorrhage
  27. Early vs Delayed Cerebral Infarction After Aneurysm Repair After Subarachnoid Hemorrhage
  28. Controversy: Does Prevention of Vasospasm in Subarachnoid Hemorrhage Improve Clinical Outcome?
  29. The Relationship Between Delayed Infarcts and Angiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage
  30. New trends in hyperosmolar therapy?
  31. Acute Stroke Care
  32. Response to a bolus of conivaptan in patients with acute hyponatremia after brain injury
  33. Effect of osmotic agents on regional cerebral blood flow in traumatic brain injury
  34. Diagnostic yield of computed tomography angiography and magnetic resonance angiography in patients with catheter angiography–negative subarachnoid hemorrhage
  35. Hemostatic Therapy Should Be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
  36. Diagnostic Yield of Repeat Catheter Angiography in Patients With Catheter and Computed Tomography Angiography Negative Subarachnoid Hemorrhage
  37. Effect of Mannitol on Cerebral Blood Volume in Patients With Head Injury
  38. Post-Procedural Management of Patients with Aneurysmal Subarachnoid Hemorrhage
  39. Relationship Between Angiographic Vasospasm and Regional Hypoperfusion in Aneurysmal Subarachnoid Hemorrhage
  40. Editorial: Ischemia
  41. Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage
  42. The Risks of Blood Transfusion in Patients with Subarachnoid Hemorrhage: Response to Dr. Paul E. Marik
  43. Statins and Anti-Inflammatory Therapies for Subarachnoid Hemorrhage
  44. Year in review 2011: Critical Care - neurocritical care
  45. Does Ischemia Contribute to Energy Failure in Severe TBI?
  46. Neurocritical Care
  47. Clinical Trial Design in the Neurocritical Care Unit
  48. High-Volume Centers
  49. Critical Care Management of Patients Following Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference
  50. Poor Correlation Between Perihematomal MRI Hyperintensity and Brain Swelling After Intracerebral Hemorrhage
  51. A Prospective Randomized Study to Evaluate the Antipyretic Effect of the Combination of Acetaminophen and Ibuprofen in Neurological ICU Patients
  52. Comparison of Short-Duration Levetiracetam with Extended-Course Phenytoin for Seizure Prophylaxis After Subarachnoid Hemorrhage
  53. Red blood cell transfusion in patients with subarachnoid hemorrhage: a multidisciplinary North American survey
  54. Year in review 2010: Critical Care - neurocritical care
  55. Cerebral Hemodynamic and Metabolic Effects of Equi-Osmolar Doses Mannitol and 23.4% Saline in Patients with Edema Following Large Ischemic Stroke
  56. Reducing the Incidence of Intraventricular Catheter–Related Ventriculitis in the Neurology-Neurosurgical Intensive Care Unit at a Tertiary Care Center in St Louis, Missouri: An 8-Year Follow-Up Study
  57. Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group
  58. Sodium Disturbances Commonly Encountered in the Neurologic Intensive Care Unit
  59. Early Endovascular Coiling of Posterior Communicating Artery Saccular Aneurysm in the Setting of Staphylococcus Bacteremia
  60. Handbook of Neurocritical Care
  61. Thromboembolic Events With Recombinant Activated Factor VII in Spontaneous Intracerebral Hemorrhage: Results From the Factor Seven for Acute Hemorrhagic Stroke (FAST) Trial
  62. Autoregulation after ischaemic stroke
  63. Near-complete resolution of angiographic cerebral vasospasm after extreme elevation of mean arterial pressure: case report
  64. Factors Associated with the Development of Anemia After Subarachnoid Hemorrhage
  65. Red Blood Cell Transfusion Increases Cerebral Oxygen Delivery in Anemic Patients With Subarachnoid Hemorrhage
  66. Intensive care treatment of aneurysmal subarachnoid hemorrhage
  67. UPDATE ON INTRACEREBRAL HEMORRHAGE
  68. Editorial introductions
  69. Density and Shape as CT Predictors of Intracerebral Hemorrhage Growth
  70. Hyperoxia and traumatic brain injury
  71. Management of aneurysmal subarachnoid hemorrhage
  72. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
  73. Can a Subset of Intracerebral Hemorrhage Patients Benefit From Hemostatic Therapy With Recombinant Activated Factor VII?
  74. Conivaptan Bolus Dosing for the Correction of Hyponatremia in the Neurointensive Care Unit
  75. Neurointensivists: Part of the problem or part of the solution?
  76. Variation in Osmotic Response to Sustained Mannitol Administration
  77. Timing Is Everything in Intracerebral Hemorrhage
  78. Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
  79. Temperature Management in Acute Neurologic Disorders
  80. Hypothermia for Refractory Status Epilepticus
  81. Hyperoxia: good or bad for the injured brain?
  82. Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage
  83. The Burden of the Systemic Inflammatory Response Predicts Vasospasm and Outcome after Subarachnoid Hemorrhage
  84. WITHHOLDING CARE IN INTRACEREBRAL HEMORRHAGE: REALISTIC COMPASSION OR SELF-FULFILLING PROPHECY?
  85. Fever control and its impact on outcomes: What is the evidence?
  86. Suprapetrosal Craniotomy
  87. Factor VIIa for ICH: Behind the Scenes of an Academic–Industry Collaborative Trial
  88. Withholding care in intracerebral hemorrhage: Realistic compassion or self-fulfilling prophecy?
  89. Effect of hyperoxia on cerebral metabolic rate for oxygen measured using positron emission tomography in patients with acute severe head injury
  90. Hemodynamic manipulation in the neuro–intensive care unit: cerebral perfusion pressure therapy in head injury and hemodynamic augmentation for cerebral vasospasm
  91. Is there a role for hyperoxia in the management of severe traumatic brain injury?
  92. Determinants of Intracerebral Hemorrhage Growth: An Exploratory Analysis
  93. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures
  94. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage
  95. Impact of Recombinant Activated Factor VII on Health-Related Quality of Life after Intracerebral Hemorrhage
  96. Dynamics of Intraventricular Hemorrhage in Patients with Spontaneous Intracerebral Hemorrhage: Risk Factors, Clinical Impact, and Effect of Hemostatic Therapy with Recombinant Activated Factor VII
  97. Temperature Management in Acute Neurologic Disorders
  98. Factors predicting prognosis after decompressive hemicraniectomy for hemispheric infarction
  99. Perihematomal Mitochondrial Dysfunction After Intracerebral Hemorrhage
  100. Hypernatremia in the neurologic intensive care unit: how high is too high?
  101. Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage
  102. Hyponatremia in Neurologic Patients: Consequences and Approaches to Treatment
  103. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage
  104. Response to discussion by Dr Philip Hébert
  105. Is aggressive treatment of hyperglycemia for everyone?*
  106. Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage: US Phase IIA Trial
  107. Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions
  108. Osmolality not predictive of mannitol-induced acute renal insufficiency
  109. Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage
  110. Treatment of severe coagulopathy after gunshot injury to the head using recombinant activated factor VII
  111. To clip or to coil acutely ruptured intracranial aneurysms: update on the debate
  112. Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
  113. Neurointensivists' Opinions About Death by Neurological Criteria and Organ Donation
  114. Use of Recombinant Factor VIIa in Patients With Warfarin-Associated Intracranial Hemorrhage
  115. Safety and Feasibility of Recombinant Factor VIIa for Acute Intracerebral Hemorrhage
  116. Bringing order to chaos*
  117. Errata
  118. Hourly Blood Pressure Monitoring After Intravenous Tissue Plasminogen Activator for Ischemic Stroke: Does Everyone Need It?
  119. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients*
  120. Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations
  121. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system
  122. CoolGard/Cool Line™ Catheter System
  123. Osmotic Therapy: Fact and Fiction
  124. Evidence-Based Medicine
  125. Testing the Utility of an Intervention
  126. Subarachnoid hemorrhage: A multiple-organ system disease *
  127. Evidence-based medicine: What do you do when there’s no evidence? *
  128. Sensitivity to changes in disability after stroke: A comparison of four scales useful in clinical trials
  129. Regional cerebrovascular and metabolic effects of hyperventilation after severe traumatic brain injury
  130. No reduction in cerebral metabolism as a result of early moderate hyperventilation following severe traumatic brain injury
  131. Correction for Partial Volume Effects in Regional Blood Flow Measurements Adjacent to Hematomas in Humans with Intracerebral Hemorrhage: Implementation and Validation
  132. Cerebral Hemodynamic and Metabolic Changes Caused by Brain Retraction after Aneurysmal Subarachnoid Hemorrhage
  133. THE USE OF HYPERVENTILATION AND ITS IMPACT ON CEREBRAL ISCHEMIA IN THE TREATMENT OF TRAUMATIC BRAIN INJURY
  134. Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage
  135. Sodium and Water Regulation in a Patient With Cerebral Salt Wasting
  136. Effect of fusaric acid on aggression, motor activity, and brain monoamines in mice
  137. Use of gastric fistula rats for the study of sedative, hypnotic and antianxiety drugs
  138. Cerebral blood flow
  139. Management of vasospasm in subarachnoid hemorrhage
  140. Foreword